150 related articles for article (PubMed ID: 15075379)
1. Abolition of valproate-derived choleresis in the Mrp2 transporter-deficient rat.
Wright AW; Dickinson RG
J Pharmacol Exp Ther; 2004 Aug; 310(2):584-8. PubMed ID: 15075379
[TBL] [Abstract][Full Text] [Related]
2. Mrp2 is involved in benzylpenicillin-induced choleresis.
Ito K; Koresawa T; Nakano K; Horie T
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G42-9. PubMed ID: 15194559
[TBL] [Abstract][Full Text] [Related]
3. Choleretic effect of valproic acid in the rat.
Watkins JB; Klaassen CD
Hepatology; 1981; 1(4):341-7. PubMed ID: 6793496
[TBL] [Abstract][Full Text] [Related]
4. An osmotic explanation for valproic acid induced choleresis in the rat, dog and monkey.
Dickinson RG; Harland RC; Kaufman SN; Lynn RK; Gerber N
Arzneimittelforschung; 1982; 32(3):241-7. PubMed ID: 6805484
[TBL] [Abstract][Full Text] [Related]
5. 4-Hydroxyacetophenone-induced choleresis in rats is mediated by the Mrp2-dependent biliary secretion of its glucuronide conjugate.
Mahagita C; Tanphichai K; Suksamrarn A; Ballatori N; Piyachaturawat P
Pharm Res; 2006 Nov; 23(11):2603-10. PubMed ID: 17009103
[TBL] [Abstract][Full Text] [Related]
6. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
Shoda J; Miura T; Utsunomiya H; Oda K; Yamamoto M; Kano M; Ikegami T; Tanaka N; Akita H; Ito K; Suzuki H; Sugiyama Y
Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
[TBL] [Abstract][Full Text] [Related]
7. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
Watkins JB; Klaassen CD
J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
[TBL] [Abstract][Full Text] [Related]
9. Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1.
Zamek-Gliszczynski MJ; Hoffmaster KA; Tian X; Zhao R; Polli JW; Humphreys JE; Webster LO; Bridges AS; Kalvass JC; Brouwer KL
Drug Metab Dispos; 2005 Aug; 33(8):1158-65. PubMed ID: 15860656
[TBL] [Abstract][Full Text] [Related]
10. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.
Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N
J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116
[TBL] [Abstract][Full Text] [Related]
11. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in spironolactone-induced choleresis in the rat. Role of multidrug resistance-associated protein 2.
Ruiz ML; Villanueva SS; Luquita MG; Sánchez-Pozzi EJ; Crocenzi FA; Pellegrino JM; Ochoa JE; Vore M; Mottino AD; Catania VA
Biochem Pharmacol; 2005 Feb; 69(3):531-9. PubMed ID: 15652244
[TBL] [Abstract][Full Text] [Related]
13. Phloracetophenone-induced choleresis in rats is mediated through Mrp2.
Tradtrantip L; Piyachaturawat P; Soroka CJ; Harry K; Mennone A; Mahagita C; Ballatori N; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G66-74. PubMed ID: 17363469
[TBL] [Abstract][Full Text] [Related]
14. Choleretic and diuretic properties of dihydroxydibutyl ether in the rat.
Corbic M; Dumont M; De Couët G; Erlinger S
J Pharmacol Exp Ther; 1982 Jun; 221(3):769-74. PubMed ID: 7086686
[TBL] [Abstract][Full Text] [Related]
15. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
16. Biliary and urinary excretion of drug conjugates: effect of diuresis and choleresis on excretion of harmol sulphate and harmol glucuronide in the rat.
Jorritsma J; Meerman JH; Vonk RJ; Mulder GJ
Xenobiotica; 1979 Apr; 9(4):247-52. PubMed ID: 483860
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance-associated protein 2 is primarily responsible for the biliary excretion of fexofenadine in mice.
Tian X; Zamek-Gliszczynski MJ; Li J; Bridges AS; Nezasa K; Patel NJ; Raub TJ; Brouwer KL
Drug Metab Dispos; 2008 Jan; 36(1):61-4. PubMed ID: 17913796
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats.
Chen C; Hennig GE; Manautou JE
Drug Metab Dispos; 2003 Jun; 31(6):798-804. PubMed ID: 12756215
[TBL] [Abstract][Full Text] [Related]
19. Biliary excretion of azelnidipine, a calcium antagonist, in rats.
Hanawa N; Sano N; Takikawa H
J Gastroenterol Hepatol; 2004 Apr; 19(4):413-7. PubMed ID: 15012778
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
Maier-Salamon A; Hagenauer B; Reznicek G; Szekeres T; Thalhammer T; Jäger W
J Pharm Sci; 2008 Apr; 97(4):1615-28. PubMed ID: 17724663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
